Form D · Pharmaceuticals
Marius Pharmaceuticals, LLC
Raleigh, NC · CIK 0001777443
Offering snapshot reported Oct 5, 2021 · SEC filing
- Reported sold
- $6.01M Offering amount: $6.01M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 12
- Minimum accepted$2,000,000 → $0
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2021 | Amendment | $6,006,000 | No comparison | 12 | SEC filing |
| Jun 26, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 22, 2019 | Initial | $5,603,850 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342840
Includes $2MM of equity sold in July 2020 at similar valuation
Source: Form D, filed Oct 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Om Dhingra | Director |
| Shalin Shah | Executive |
| Amit Shah | Director |
| Himanshu H. Shah | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8601 Six Forks Road Suite 630
Raleigh, NC, 27615
Raleigh, NC, 27615